MBP
Click for more information
3.23% 3.0¢ metabolic pharmaceuticals limited

quarterly report or lack thereof

  1. abeaty
    1,127 Posts.
    lightbulb Created with Sketch. 83
    clock Created with Sketch.
    16/07/07
    15:07
    Post #: 2624300
    Just spoke to MBP suggesting their quarterly report was kind of overdue.

    They advised they have opted to hold fire until they release the results of the ACV1 Neuropathic Pain Phase 2 study.

    And, as the study is over and results are being compiled keep an eye on the price to give an indication of which way the insiders are calling it!

    Did I say that, shame on me ASIC. Losers!
    MBP Price at posting: 0.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Chris Judd's Talk Ya Book: Tracking Life360 on a journey to the stars
right-arrow Created with Sketch.
CC9 Chariot Corporation marches forward with discovery-level drill program in Wyoming, USA
right-arrow Created with Sketch.
HAR Haranga resource upgrade builds confidence in Saraya uranium project
right-arrow Created with Sketch.
RDN If you thought lithium was dead, think again. The Pilbara will be central to the next upswing
right-arrow Created with Sketch.
NEWS Hillcrest Partners with Ocean Batteries to Deploy ZVS Invert
right-arrow Created with Sketch.
FHE Frontier Energy achieves key milestone for Waroona energy project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.